- Home
- PBYI vs UHG Comparison
PBYI vs UHG Comparison
Compare PBYI & UHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- UHG
- Stock Information
- Founded
- PBYI 2010
- UHG 2004
- Country
- PBYI United States
- UHG United States
- Employees
- PBYI N/A
- UHG N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- UHG Homebuilding
- Sector
- PBYI Health Care
- UHG Consumer Discretionary
- Exchange
- PBYI Nasdaq
- UHG Nasdaq
- Market Cap
- PBYI 263.4M
- UHG 248.7M
- IPO Year
- PBYI N/A
- UHG N/A
- Fundamental
- Price
- PBYI $4.91
- UHG $1.26
- Analyst Decision
- PBYI Strong Buy
- UHG
- Analyst Count
- PBYI 1
- UHG 0
- Target Price
- PBYI $7.00
- UHG N/A
- AVG Volume (30 Days)
- PBYI 635.5K
- UHG 734.1K
- Earning Date
- PBYI 11-06-2025
- UHG 11-06-2025
- Dividend Yield
- PBYI N/A
- UHG N/A
- EPS Growth
- PBYI 59.87
- UHG N/A
- EPS
- PBYI 0.74
- UHG N/A
- Revenue
- PBYI $211,995,000.00
- UHG $418,113,017.00
- Revenue This Year
- PBYI N/A
- UHG N/A
- Revenue Next Year
- PBYI N/A
- UHG N/A
- P/E Ratio
- PBYI $6.61
- UHG N/A
- Revenue Growth
- PBYI N/A
- UHG N/A
- 52 Week Low
- PBYI $2.32
- UHG $1.25
- 52 Week High
- PBYI $6.12
- UHG $6.69
- Technical
- Relative Strength Index (RSI)
- PBYI 46.97
- UHG 22.84
- Support Level
- PBYI $4.58
- UHG $1.26
- Resistance Level
- PBYI $6.12
- UHG $1.48
- Average True Range (ATR)
- PBYI 0.40
- UHG 0.11
- MACD
- PBYI -0.05
- UHG 0.05
- Stochastic Oscillator
- PBYI 20.06
- UHG 5.00
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About UHG United Homes Group Inc
United Homes Group Inc operates as a homebuilder which operates with a land-light idea in the Southeast. The company currently has a presence in South Carolina, North Carolina, and Georgia and focuses on providing high-quality, affordable homes for the entry-level and first-move-up segments. The company has three reportable segments: GSH South Carolina, Rosewood, and Other.